RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 34 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,743,031 | +16.0% | 886,075 | 0.0% | 2.78% | -2.4% |
Q2 2023 | $5,812,652 | +9.7% | 886,075 | 0.0% | 2.85% | +11.6% |
Q1 2023 | $5,298,729 | +156.7% | 886,075 | 0.0% | 2.55% | +87.1% |
Q4 2022 | $2,064,555 | -30.4% | 886,075 | 0.0% | 1.36% | -30.8% |
Q3 2022 | $2,968,000 | +26.4% | 886,075 | 0.0% | 1.97% | +17.7% |
Q2 2022 | $2,348,000 | -9.9% | 886,075 | 0.0% | 1.68% | +19.1% |
Q1 2022 | $2,605,000 | -65.6% | 886,075 | 0.0% | 1.41% | -47.4% |
Q4 2021 | $7,576,000 | +14.8% | 886,075 | 0.0% | 2.67% | +103.1% |
Q3 2021 | $6,601,000 | -20.2% | 886,075 | 0.0% | 1.32% | -0.6% |
Q2 2021 | $8,267,000 | – | 886,075 | – | 1.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
Ergoteles LLC | 37,640 | $126,000 | 0.00% |
MAI Capital Management | 63,210 | $212,000 | 0.00% |
RBF Capital, LLC | 14,536 | $49,000 | 0.00% |